Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03276637 · ClinicalTrials.gov registry record · NA
Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT03276637 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 105 participants.
The verdict
NCT03276637, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
The MilSeq Project is a nonrandomized, prospective pilot study of whole exome sequencing (WES) in the U.S. Air Force. The purpose of this study is to explore the implementation of WES into clinical medical care in the military health system.
Interventions
- GENETIC Whole exome sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2017-08-23 |
| Est. Completion | 2020-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03276637
The ClinicalTrials.gov registry entry for NCT03276637 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole exome sequencing is the first listed.
NCT03276637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03276637 about?
NCT03276637 is a clinical study titled "Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force". The MilSeq Project is a nonrandomized, prospective pilot study of whole exome sequencing (WES) in the U.S. Air Force. The purpose of this study is to explore the implementation of WES into clinical medical care in the military health system.
What is the current status of trial NCT03276637?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2017-08-23. Estimated completion is 2020-01-11.
What interventions are being tested in trial NCT03276637?
The interventions under investigation include: Whole exome sequencing (GENETIC).
Who is sponsoring clinical trial NCT03276637?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.